Related Experiment Videos
Using HER2 to choose chemotherapy in breast cancer: is it ready for the clinic?
Journal of the National Cancer Institute
|January 29, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.
Internal medicine journal·2016
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Internal medicine journal·2014
Lifestyle and chemotherapy shape functional aging trajectories in older breast cancer survivors and matched comparators.
Journal of the National Cancer Institute·2026
Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysis.
Journal of the National Cancer Institute·2026
Effectiveness of an eHealth intervention to improve quality of life in long-term breast cancer survivors: a 9-month randomized controlled trial.
Journal of the National Cancer Institute·2026
Antidepressant and antipsychotic prescriptions among 21 605 English survivors of childhood cancer: a population-based cohort.
Journal of the National Cancer Institute·2026
Recent advancements in gynecologic cancer research: a SPORE investigators meeting report.
Journal of the National Cancer Institute·2026
Breast cancer overdiagnosis in mammography trials-separating signal from noise: a meta-analysis.
Journal of the National Cancer Institute·2026
Trends in the sex ratio of cannabis use, harms and perceptions among youth in Ontario, Canada, 1999 to 2023.
Addiction (Abingdon, England)·2026
Effectiveness of colchicine preparation switching in pediatric colchicine-resistant familial Mediterranean fever: a real-world study.
European journal of pediatrics·2026
AOH1996, an Inhibitor of PCNA, Sensitises Breast Cancer Cells to Cytotoxic Chemotherapy.
Breast cancer (Dove Medical Press)·2026